Navigation Links
New conference tackles the tough questions in lung cancer
Date:4/4/2008

Lugano, Switzerland, 4th April 2008 Experts from around the world are gathering in Geneva next month at a new conference that aims to improve lung cancer treatment and answer unsolved questions about a disease that kills 1.5 million people each year.

The First European Lung Cancer Conference is an initiative of the International Association for the Study of Lung Cancer (IASLC) and the European Society for Medical Oncology (ESMO). It will be held from 23 to 26 April.

"The main objective of this meeting is to advance the quality of lung cancer treatment and find answers to unsolved problems which can contribute substantially to the improvement of patient survival," said Prof. Franoise Mornex, France, Scientific Co-Chair of the conference.

The meeting will include new scientific and clinical results from presented abstracts, as well as invited plenary speeches from top international experts.

Prof. Joseph Nevins from the Duke University Medical Center, US and Prof. David Beer from the University of Michigan, US will present new data showing how genetic signatures in early lung cancer can help doctors tailor treatments more effectively.

"The current methods for staging early lung cancer have limited success in predicting which patients will be cured and which will have cancer recurrence," says Prof. Rafael Rosell, Spain, the other Scientific Co-Chair of the conference. "This is a good example of one of the unsolved problems in lung cancer treatment we hope to address at this meeting."

Two significant controversy sessions will address new concepts in the treatment of both early and advanced lung cancer, announces Prof. Mornex: the use of alternative efficient treatments such as radiofrequency and radiation versus surgery in early lung cancer, and the role of surgery as a standard treatment for stage III non-small-cell lung cancer.

Other highlights of the conference will include a report about a new, highly accurate diagnostic test for lung squamous cell carcinoma, studies probing the role human viruses play in lung cancers, positive results from a trial of immunotherapy to treat lung cancer, and efficacy and safety results from an interim analysis of a phase III trial on stage IIIB-IV nonsmall-cell lung cancer.

"The conference will also feature workshops on molecular biology and targeted therapies that embody part of the future of lung cancer treatment," said Prof. Rosell.

"We hope that the work presented at the conference in these areas will contribute to great advances for many lung cancer patients."


'/>"/>

Contact: Vanessa Pavinato
media@esmo.org
41-919-731-907
European Society for Medical Oncology
Source:Eurekalert

Related medicine news :

1. SXC Health Solutions to Present at the Suntrust 37th Annual Institutional Conference
2. Covance Inc. Invites You to Join the Webcast of Its First Quarter 2008 Financial Results Conference Call
3. Ventas to Present at Credit Suisse 2008 Global Real Estate Conference
4. Lilly Adjusts Time of Conference Call for First Quarter 2008 Financial Results Announcement
5. Hospice Community to Focus on Advocacy at National Leadership Conference
6. Zimmer Holdings Announces Live Audio Webcast and Conference Call of First Quarter 2008 Results
7. Running Pioneer Kathrine Switzer Will Headline Women on the Move Conference August 13-15, 2008 in Spearfish, SD
8. Shannon Brownlee, Author of Overtreated, to Keynote at Defined Healths 8th Annual Therapeutic Insight Conference
9. Abbott Hosts Conference Call for First-Quarter Earnings
10. Latest Advances in Diabetes Research to be Presented in San Francisco, California at Worlds Largest Diabetes Conference, June 6-10, 2008
11. USAID Participates in White House Office of Faith-Based and Community Initiatives Conferences in Rwanda and Zambia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... ... May 26, 2016 , ... Cabot Corporation, Pfizer, and ... according to court documents and SEC filings. A jury has returned a ... American Optical Corporation, Case No. BC588866, Los Angeles County, California. The jury awarded ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... ... in intellectual property (IP) to its specialty academic programs. , Answering to the ... college’s existing certificate programs in health law, and environmental and land use law. ...
(Date:5/26/2016)... ... May 26, 2016 , ... On Memorial Day, Hope For Heroes ... in military battle for the country. The nonprofit Hope For Heroes partnered with ... that empower independence for disabled military veterans, as well as police, firemen, and EMS ...
(Date:5/26/2016)... ... 2016 , ... Cardiac arrhythmia is a common complication following ... survival, reports a team of UPMC researchers in the largest study of its ... Thoracic and Cardiovascular Surgery, provide critical information that will hopefully lead to better ...
(Date:5/26/2016)... , ... May 26, 2016 , ... MadgeTech will be ... engineered, and manufactured in Warner, New Hampshire at the MadgeTech headquarters. With products sold ... monitoring solutions trusted by government agencies, including NASA. , In 2012, NASA strategically ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)... Cirujanos holandeses han puesto en ... médicos a compartir sus mejores prácticas por el mundo ... médicos de Europa, África, Asia ... aplicación, que combina la transmisión en vivo con mensajería ... Educación   "Imagine un médico de Medicines ...
(Date:5/24/2016)... 24, 2016   , ... in overall bowel cleansing and superiority in ... leansing of the ascending ... , Norgine B.V. today announced new positive data from ... ascorbate bowel preparation) versus standard 2 litre PEG with ascorbate. The ...
(Date:5/24/2016)... -- ARANZ Medical  Ltd a specialist in ... been named the Coretex Hi-Tech Emerging Company of the Year ... Bruce Davey , CEO of ARANZ Medical says, "This ... to be recognised for the work we are doing to ... 35 countries around the world from Sub-Saharan Africa through to ...
Breaking Medicine Technology: